News Pfizer Limited Bombay S.E.

Equities

PFIZER

INE182A01018

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-03 am EDT			5-day change	1st Jan Change
4,746 ^INR	+3.17%		+5.62%	+11.18%

May. 17	Pfizer Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
May. 17	Pfizer Limited Recommends Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pfizer : Audited Results – Year ended March 31, 2024	May. 18	PU
Pfizer Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 17	CI
Pfizer Limited Recommends Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024	May. 17	CI
Pfizer Limited has Received an Order Issued by the Assistant Commissioner, GST & Central Excise, Bhubaneswar-II Division Bhubaneswar	May. 02	CI
Pfizer Limited Receives Order from Deputy Commissioner, Dehradun - Sector 8: Uttarakhand	Apr. 25	CI
Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	Apr. 02	CI
Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	Apr. 02	CI
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	Mar. 28	CI
Pfizer Limited Receives an Order from Joint Commissioner of State Tax Basis the GST Audit Conducted for Uttar Pradesh State for the Financial Year 2018-19	Mar. 22	CI
Pfizer Limited Receives an Order from Deputy Commissioner of State Tax Basis the GST Audit Conducted for the Financial Year 2018-19	Mar. 19	CI
Pfizer Limited Informs Satyen Amin, Lead - Market Access Tenders His Resignation from Employment, with Effect from March 31, 2024	Feb. 09	CI
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Pfizer Ltd. Names CFO	Jan. 21	MT
Pfizer CFO Retires	Dec. 01	MT
Pfizer Limited Announces Retirement of Mr. Milind Patil as Chief Financial Officer	Nov. 30	CI
Pfizer Limited Appoints Ms. Aditi Mehta as Category Lead, Vaccines Effective December 1, 2023	Nov. 16	CI
Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023	Nov. 13	CI
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	23-10-30	MT
Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors	23-10-28	CI
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pfizer Limited Bombay S.E.

Equities

PFIZER

INE182A01018

Summary

Filters